Tandem Diabetes Care, Inc. (NASDAQ:TNDM) has agreed to pay Roche $36 million to resolve a patent infringement lawsuit over Tandem’s t:slim X2 insulin pump. The deal settles all pending and ...

Biotium, proudly expands its trusted Cheetah™ Taq DNA Polymerase line with two new formulations: Cheetah™ FLEX HotStart Taq DNA Polymerase and Cheetah™ PEA-PLEX HotStart Taq DNA Polymerase. These ...

A group of advisers to the Food and Drug Administration said Roche Holding AG needs to study its blood cancer treatment in more American patients before its use can be expanded.

The new facility will ultimately support Roche and Genentech’s future portfolio of next-generation obesity medicines and this initial investment could expand in the future based on business ...

Roche will invest $550 million in Indianapolis for a new manufacturing facility for glucose monitoring devices, adding several hundred jobs.

Roche said the investment would go toward high-tech research and development sites and new manufacturing facilities in places including Pennsylvania.

Roche and Zealand reason petrelintide could deliver weight loss comparable to glucagon-like peptide 1 (GLP-1) receptor agonists but without the side effects associated with GLP-1 drugs.

Roche has recently launched a “fundamental reorganization” of its Spark Therapeutics gene therapy unit and recorded a $2.4 billion full impairment.

Roche has signed a new biobucks-heavy pact that aims to add another new antibody-drug conjugate asset to its pipeline.

Roche is considering divesting Flatiron Health six years after it bought the startup for $1.9 billion, according to a media report.

Roche has sued Stanford University and medical technology startup Foresight Diagnostics in California federal court, claiming Foresight misused its genetic-sequencing trade secrets to develop ...